Brief: Selectimmune Pharma Announces Preliminary Results From New Pre-Clinical Study
Oct 7 (Reuters) - Selectimmune Pharma AB SELECTb.TE :
* ANNOUNCES PRELIMINARY RESULTS FROM NEW PRE-CLINICAL STUDY
* STUDY SHOWS CO'S IMMUNOTHERAPY FOR BLADDER INFECTION WORKS
JUST
AS WELL AS ANTIBIOTICS IN ANIMAL MODEL
Source text for Eikon: ID:nWkr8X4mpg
Further company coverage: SELECTb.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Selectimmune Pharma AB
See all newsBrief: Selectimmune Pharma Says Co's CEO Ann Gidner Will Leave Selectimmune Pharma
Brief: Lonza Collaborates With Selectimmune Collaborates To Develop Immunotherapeutic Drug Candidate
Brief: Selectimmune Pharma Q2 Pretax Loss Widens To SEK 3.1 Mln
Brief: Selectimmune Pharma Q1 Pretax Loss Narrows To SEK 2.2 Million
Brief: Selectimmune Pharma Signs Deal On Phase II Study For Infection Treatment